Asunto(s)
Disnea , Síndrome de Dificultad Respiratoria , Femenino , Humanos , Adulto Joven , Adulto , Disnea/diagnóstico , Disnea/etiología , Fiebre/diagnóstico , Fiebre/etiologíaRESUMEN
INTRODUCTION: Hypercalcemia is a common pathological condition in clinical practice. The two most common causes are primary hyperparathyroidism and cancer. SIADH is often encountered in cancer cases and is the most common cause of hyponatremia. The aim of this study is to evaluate serum sodium levels in a cohort of patients with hypercalcemia and consider its predictive value in determining the origin of this hypercalcemia. MATERIALS AND METHODS: We performed a retrospective study on a series of 15.284 blood tests among adult patients with hypercalcemia. After selection, the study population had 151 patients. We studied mainly serum sodium and etiology of hypercalcemia in our population. RESULTS: We observed a statistically significant association between the presence of hyponatremia and the neoplastic etiology of hypercalcemia. This association persisted after exclusion of patients under treatment with loop diuretics. Conversely, there was no association between hypernatremia and cancer-related hypercalcemia. Among 151 patients with hypercalcemia, 16 presented hyponatremia and 7 with hypernatremia. SIADH was the main cause of hyponatremia. We performed univariate and multivariate logistic regression showing the association between the presence of cancer and the presence of hyponatremia. CONCLUSION: Our study shows that there is an association between the presence of hyponatremia and neoplastic origin of hypercalcemia. Besides, the association described between hyponatremia and cancer is not faulted by the presence of hypercalcemia, a potential cause of acquired nephrogenic diabetes insipidus.
INTRODUCTION: L'hypercalcémie est une condition pathologique courante en pratique clinique. Les deux causes les plus fréquentes sont l'hyperparathyroïdie primaire et le cancer. Le syndrome de sécrétion inappropriée de l'hormone antidiurétique (SIADH) est souvent rencontré dans les cas de cancer, et constitue la cause la plus fréquente d'hyponatrémie. Le but de cette étude est d'évaluer la natrémie dans une cohorte de patients atteints d'hypercalcémie et d'apprécier sa valeur prédictive dans la détermination de l'origine de cette hypercalcémie. Matériel et méthode : Nous avons réalisé une étude rétrospective sur une série de 15.284 analyses sanguines chez des patients adultes hypercalcémiques. Après sélection, la population de l'étude comptait 151 patients. Nous avons étudié principalement la natrémie et l'étiologie de l'hypercalcémie au sein de notre population. Résultats : Nous avons observé une association statistiquement significative entre la présence d'une hyponatrémie et l'étiologie néoplasique de l'hypercalcémie. Cette association persistait après l'exclusion des patients sous traitement par diurétiques de l'anse. Par contre, il n'existait pas d'association entre l'hypernatrémie et l'origine cancéreuse de l'hypercalcémie. Sur 151 patients hypercalcémiques, 16 étaient hyponatrémiques et 7 étaient hypernatrémiques. Un SIADH représentait la cause principale des cas d'hyponatrémie. Nous avons réalisé une régression logistique uni- et multivariée montrant l'association entre l'existence d'un cancer et la présence d'une hyponatrémie. CONCLUSION: Notre étude montre qu'il existe une association entre la présence d'une hyponatrémie et l'étiologie néoplasique de l'hypercalcémie. Par ailleurs, l'association classiquement décrite entre hyponatrémie et cancer n'est pas prise en défaut par la présence d'une hypercalcémie, cause potentielle de diabète insipide néphrogénique acquis.
Asunto(s)
Hipercalcemia/sangre , Hipercalcemia/diagnóstico , Sodio/sangre , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Hipercalcemia/complicaciones , Hipernatremia/sangre , Hipernatremia/complicaciones , Hipernatremia/diagnóstico , Hiponatremia/sangre , Hiponatremia/complicaciones , Hiponatremia/diagnóstico , Síndrome de Secreción Inadecuada de ADH/sangre , Síndrome de Secreción Inadecuada de ADH/complicaciones , Síndrome de Secreción Inadecuada de ADH/diagnóstico , Masculino , Persona de Mediana Edad , Neoplasias/sangre , Neoplasias/complicaciones , Neoplasias/diagnóstico , Valor Predictivo de las Pruebas , Pronóstico , Estudios Retrospectivos , Sodio/análisis , Adulto JovenRESUMEN
We report the case of a 74-year-old woman admitted to the emergency unit for resting dyspnea. Clinical presentation, cardiac MRI and echocardiography were consistent with cardiac tamponade requiring emergency pericardiocentesis. Cytologic examination of the pericardial fluid revealed the presence of CD68pos CD1aneg S100neg foamy histiocytes (Fig. 1). Additional investigations complied with the diagnosis of Erdheim-Chester histiocytosis. Treatment with αIFN was initiated but the patient developed severe neutropenia that contraindicated further administration. The detection of BRAFV600E mutation on histiocytes isolated from the pericardial liquid and CNS involvement (cerebral masses) prompted the administration of vemurafenib, a selective BRAFV600E kinase inhibitor. Four months after the initiation of low-dose vemurafenib, pericarditis almost resolved and cerebral masses decreased by 50% (Fig. 2). To our knowledge, analysis of pericardial fluid allowing the diagnosis of Erdheim-Chester disease and the detection of the BRAFV600E mutation has in fact been rarely described in the literature. This case report and the successful evolution under vemurafenib also support the use of BRAFV600E inhibitors in αIFN-intolerant patients with BRAFV600E mutation, particularly in case of heart and central nervous system involvement.
Asunto(s)
Enfermedad de Erdheim-Chester/diagnóstico , Líquido Pericárdico/citología , Anciano , Enfermedad de Erdheim-Chester/tratamiento farmacológico , Enfermedad de Erdheim-Chester/patología , Femenino , Humanos , Indoles/farmacología , Indoles/uso terapéutico , Proteínas Proto-Oncogénicas B-raf/antagonistas & inhibidores , Sulfonamidas/farmacología , Sulfonamidas/uso terapéutico , VemurafenibRESUMEN
Anti-aging medicine is self defined as a preventive medicine, combining nutritional recommendations, dietary supplements, prescriptions for hormones and various aesthetic techniques. The essential aim is to reduce the risk of aging, both psychically, physically and aesthetically. Although many scientific studies in animals or in vitro models have demonstrated the deleterious role of oxidative stress and of hormonal, vitamin or trace elements deficiencies, the transposition to humans of these findings is marginal and does not justify the therapeutic proposals advocated by the anti aging medicine. These practices are mostly not based on any scientific basis both in the diagnostic and therapeutic fields. These approaches are particularly costly for gullible patients in search of well being and abused by a carefully organized marketing involving tacit complicity of doctors, laboratories and firms producing hormones and dietary supplements and various substances devoted for aesthetic purposes.
Asunto(s)
Envejecimiento , Medicina Regenerativa , Anciano , Anciano de 80 o más Años , Envejecimiento/efectos de los fármacos , Envejecimiento/fisiología , Cosméticos/economía , Cosméticos/uso terapéutico , Suplementos Dietéticos/economía , Humanos , Mercadotecnía/ética , Medicina Regenerativa/economía , Medicina Regenerativa/ética , CienciaAsunto(s)
Síndromes Periódicos Asociados a Criopirina/diagnóstico , Enfermedades de la Piel/diagnóstico , Anciano , Sustitución de Aminoácidos , Proteínas Portadoras/análisis , Proteínas Portadoras/genética , Enfermedad Crónica , Síndromes Periódicos Asociados a Criopirina/genética , Diagnóstico Diferencial , Femenino , Humanos , Proteína con Dominio Pirina 3 de la Familia NLRRESUMEN
This work constitutes a argued analysis of the publication of the article of Hertoghe et al. "Anti aging medicine, a science based, essential medicine " whose full and unreviewed publication was forced in the framework of the Belgian law on the right of reply to an earlier publication entitled " Anti-Aging Medicine: Science or Marketing? ". We confirm the absence of scientific evidence on the effectiveness of hormonal treatments used in this approach by highlighting the different techniques allowing doctors who promote this approach to make believe in their effectiveness. This is clearly to mix in one sentence established truths and unproven facts, use references inappropriately especially by misappropriation of studies on groups of patients with hormone deficiency in order to justify treatment in healthy subjects, to ignore recent references undermining ancient literature, to betray the authors' conclusions. Our critical analysis is also considering compliance with the guidelines for integrity in scientific publications.
Asunto(s)
Envejecimiento , Geriatría , HumanosAsunto(s)
Anemia/etiología , Edema/etiología , Infecciones por Parvoviridae/complicaciones , Adulto , Anemia/diagnóstico , Anemia/virología , Ritmo Circadiano , Edema/virología , Cara , Femenino , Humanos , Infecciones por Parvoviridae/diagnóstico , Parvovirus B19 Humano/genética , Parvovirus B19 Humano/aislamiento & purificación , Insuficiencia Renal/complicaciones , Insuficiencia Renal/diagnóstico , Insuficiencia Renal/virologíaAsunto(s)
Enfermedad por Rasguño de Gato/diagnóstico , Disuria/complicaciones , Fiebre/complicaciones , Cefalea/complicaciones , Adulto , Animales , Bartonella henselae/aislamiento & purificación , Enfermedad por Rasguño de Gato/microbiología , Gatos , Diagnóstico Diferencial , Disuria/diagnóstico , Disuria/microbiología , Fiebre/diagnóstico , Fiebre/microbiología , Cefalea/diagnóstico , Cefalea/microbiología , Humanos , Masculino , Mascotas , Tomografía de Emisión de Positrones , Zoonosis/diagnósticoRESUMEN
In addition to osteomalacia and rickets which are the main classical consequences of severe vitamin D deficiency, osteoporosis and extra skeletal manifestations were more recently linked to decreased vitamin D levels. Painful myopathy, cancer, autoimmune disorders and probably cardiovascular events are also more prevalent in vitamin D deficient adults. Elderly people and pregnant women are the main groups at risk of vitamin D depletion. The recommendations of photoprotective regimen to protect against skin cancer are in part responsible for the increased prevalence of vitamin D deficiency. We here review the management of vitamin D deficiency and the current recommendations for vitamin D repletion in specific groups of subjects with overt vitamin D depletion or at risk to be deficient.
Asunto(s)
Conservadores de la Densidad Ósea/uso terapéutico , Vitamina D/uso terapéutico , Dieta , Femenino , Humanos , Masculino , Embarazo , Medición de Riesgo , Deficiencia de Vitamina D/complicacionesRESUMEN
Respiratory symptoms are rare manifestations of ulcerative colitis as well as intestinal manifestations in Wegener granulomatosis. We report the case of a 17-year old man previously diagnosed as having ulcerative colitis who presented with diffuse thoracic pain. Hypermetabolic pulmonary nodules were discovered at the positron emission tomographic scan. Necrotizing granulomatous vasculitis was demonstrated at lung biopsy. In this paper, we describe the association between pulmonary nodules and ulcerative colitis and we discuss the possibility of an overlap syndrome between ulcerative colitis and Wegener granulomatosis.
Asunto(s)
Colitis Ulcerosa/complicaciones , Granuloma/etiología , Granulomatosis con Poliangitis/complicaciones , Enfermedades Pulmonares/etiología , Vasculitis/etiología , Adolescente , Granuloma/patología , Humanos , Enfermedades Pulmonares/patología , Masculino , Necrosis , Vasculitis/patologíaRESUMEN
In the framework of implementation of his national program for control and prevention of cardiovascular diseases, Cameroonian government has set up a cardiac surgery project. We report in this manuscript results of one year follow up of the patients operated during the pilot phase. From September 22 till 26, 2008, 11 patients have been operated in Cameroun. Surgical procedures were 5 mitral mechanic valve replacement, 2 aortic mechanic valve replacement, 1 atrial septal defect closure, 2 pace maker implantation. No intrahospital death was observed. One patient died at 11th month after the operation due to mitral valve thrombosis and attributed to lack of compliance. One patient presented low cardiac output, pneumonia and a pleural effusion. 2 patients presented 2 minor complications consisting of pericarditis and superficial wound infection. The results of the pilot phase of cardiac surgery in Cameroon are effective. However, the sustainability of the program require human, material capacity building, and funding mechanism as well.
Asunto(s)
Procedimientos Quirúrgicos Cardíacos/estadística & datos numéricos , Adulto , Camerún , Femenino , Cardiopatías/cirugía , Humanos , Masculino , Proyectos Piloto , Complicaciones Posoperatorias/epidemiologíaRESUMEN
We report the case of a 56-year-old female who suffers from chronic urticaria and digestive symptoms, suggesting parasitic infection. Neither repetitive ova and parasite examinations in stools, nor duodenal aspiration examination reveals any parasite. The patient is treated by tinidazole, but the symptoms reappear ten days later. An additive ELISA test on stool remains positive for Giardia Lamblia; the patient receives once more tinidazole and symptoms totally disappear. This case report illustrates that the association between urticaria and digestive symptoms should guide the clinician to the diagnosis of Giardia Lamblia infection, and it shows the importance of a rapid and highly sensitive diagnostic test for giardiasis, like the ELISA test.
Asunto(s)
Giardia lamblia , Giardiasis/diagnóstico , Giardiasis/terapia , Urticaria/parasitología , Enfermedad Crónica , Femenino , Giardiasis/complicaciones , Humanos , Persona de Mediana EdadRESUMEN
We report the case of a 32-year-old patient with Wegener's granulomatosis (WG) associated with a (biopsy - proven) renal inflammatory pseudotumour (IPT) of the left kidney treated by a partial nephrectomy, glucocorticoids and immunosuppressive drugs, in whom a relapse of renal IPT was found 6 years after the diagnosis of the first IPT. The originality of this observation lies in the fact that a relapse of IPT has never been described and also in the fact that complete regression of the IPT relapse was obtained with immunosuppressive treatment, while renal IPTs are currently treated by total or partial resection of the kidney. Finally, we discuss the potential benefits of an integrated 18fluorodeoxyglucose PET/CT for the follow-up of WG, since this imaging technique contributed to the management of the present case.
Asunto(s)
Granuloma de Células Plasmáticas/diagnóstico , Granuloma de Células Plasmáticas/etiología , Granulomatosis con Poliangitis/complicaciones , Granulomatosis con Poliangitis/patología , Enfermedades Renales/diagnóstico , Enfermedades Renales/etiología , Adulto , Granuloma de Células Plasmáticas/terapia , Granulomatosis con Poliangitis/terapia , Humanos , Enfermedades Renales/terapia , RecurrenciaRESUMEN
Complementary to their specific metabolic actions, several vitamins are given for new previously unsuspected properties. In addition to its role in calcium absorption, vitamin D has been proven to possess beneficial effects for some autoimmune diseases, several cancers and cardiovascular illnesses. It also increases muscle strength and prevents falls particularly in elderly people. Low dose oral vitamin K supplementation is a new indication for people with unstable coumarinic anticoagulant treatment. Oral vitamin 812 administration is an alternative to the classical parenteral intramuscular administration in pernicious anemia. However, the possible antioxidant beneficial effects of vitamin A and E are largely disputed taking into account an increased mortality associated to their consumption.
Asunto(s)
Vitaminas/uso terapéutico , Anemia Perniciosa/tratamiento farmacológico , Antioxidantes/efectos adversos , Antioxidantes/uso terapéutico , Coagulación Sanguínea/efectos de los fármacos , Terapias Complementarias , Humanos , Vitamina B 12/efectos adversos , Vitamina B 12/uso terapéutico , Vitamina D/efectos adversos , Vitamina D/uso terapéutico , Vitamina E/uso terapéutico , Vitamina K/efectos adversos , Vitamina K/uso terapéutico , Vitaminas/efectos adversosRESUMEN
Hypereosinophilia is a common clinical finding, and is generally associated with an underlying disease, mainly parasitosis, atopic disorders, drug hypersensitivity, and certain solid and haematological malignancies. Appropriate therapeutic management requires identification of the cause, through careful clinical examination and various technical investigations. Occasionally, thorough diagnostic work-up fails to identify an underlying disorder; the term hypereosinophilic syndrome is used when moderate or severe hypereosinophilia is associated with multi-organ involvement. Indeed, whatever its cause, when the blood eosinophil level is greater than 1500 per microfiter, there is a significant risk of complications directly related to the presence of eosinophils in tissues. The major target organs are the skin, lungs, digestive system, nervous system, and the heart. Reduction of blood eosinophil levels becomes an aim in itself in such cases, and recent studies on pathogenesis of hypereosinophilic syndrome have had an impact on the choice of therapeutic agents used to this end. Imatinib has become first line treatment for a disease variant associated with a somatic mutation involving pluripotent hematopoietic stem cells that generates autonomous tyrosine kinase activity, leading to clonal expansion of eosinophils. For all other patients, gluco-corticoids remain first choice. In case of cortico-resistance or if a cortico-sparing agent is required, options include interferon-alpha, hydroxyurea, or mepolizumab, a monoclonal anti-IL-5 antibody that has recently shown efficacy as a cortico-sparing agent for hypereosinophilic syndrome in a well-conducted clinical trial.
Asunto(s)
Síndrome Hipereosinofílico/tratamiento farmacológico , Síndrome Hipereosinofílico/etiología , Benzamidas , Eosinófilos/patología , Eosinófilos/fisiología , Hipersensibilidad a los Alimentos/diagnóstico , Glucocorticoides/uso terapéutico , Enfermedades Hematológicas/complicaciones , Humanos , Síndrome Hipereosinofílico/diagnóstico , Síndrome Hipereosinofílico/genética , Mesilato de Imatinib , Recuento de Leucocitos , Mutación , Neoplasias/complicaciones , Enfermedades Parasitarias/complicaciones , Piperazinas/uso terapéutico , Prednisona/uso terapéutico , Proteínas Tirosina Quinasas/genética , Eosinofilia Pulmonar/complicaciones , Pirimidinas/uso terapéuticoRESUMEN
Scleroderma encompasses an heterogeneous group of autoimmune disorders characterized by an hidebound thickened skin involvement. When the changes are limited to the skin, localized scleroderma is suspected. Although the latter is most often a benign disease, it may be exceptionally associated with involvement of multiple organs, mainly the neurological system. At the opposite, systemic sclerosis is a serious disorder associated with high morbidity and even mortality and defined by an extended skin sclerosis, multiple organ involvement and general symptoms. Raynaud phenomena is nearly always present at the beginning of the disease. Identifying initial manifestations of the disease (Raynaud phenomena, diffuse non pitting edema, symmetrical polyarthritis with tendon friction rubs, dysphagia associated with mucosal telangiectasia) may allow the clinician to rapidly transfer the patient to a specialized reference center in order to organize a multidisciplinary approach and to prompt optimum therapy.